A male predisposition for development of amyloid heart disease has been described in non-endemic late-onset (>50 years of age) ATTR V30M patients in Japan [24], in late-onset Swedish ATTR V30M patients [7, 25], and also for other TTR mutations [26, 27]. This evidence concerns the gene TTR and cardiac amyloidosis.